Treatment modelling: The influence of micro-environmental conditions

Acta Oncologica

Volumn 47, Issue 5, 2008, Pages 896-905

  Daşu, Alexandru ^a   Toma Daşu, Iuliana ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CONTROL; CELL ENERGY; CELL SURVIVAL; CHEMICAL MODIFICATION; DNA REPAIR; HYPOXIC CELL; PRIORITY JOURNAL; RADIATION; RADIOSENSITIVITY; THEORETICAL MODEL; TUMOR CELL;

ANOXIA; CELL HYPOXIA; DNA REPAIR; HUMANS; MODELS, BIOLOGICAL; MONTE CARLO METHOD; NEOPLASMS; OXYGEN CONSUMPTION; POISSON DISTRIBUTION; PREDICTIVE VALUE OF TESTS; RADIATION EFFECTS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 45849129492     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860701716884     Document Type: Article

References (68)

1. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 1989;49:6449-65.
2. Denekamp J, Daşu A, Waites A. Vasculature and microenvironmental gradients: The missing links in novel approaches to cancer therapy? Adv Enzyme Regul 1998;38:281-99.
3. Gerweck LE, Dahlberg WK, Epstein LF, Shimm DS. Influence of nutrient and energy deprivation on cellular response to single and fractionated heat treatments. Radiat Res 1984;99:573-81.
4. Gerweck LE, Seneviratne T, Gerweck KK. Energy status and radiobiological hypoxia at specified oxygen concentrations. Radiat Res 1993;135:69-74.
5. Skøyum R, Eide K, Berg K, Rofstad EK. Energy metabolism in human melanoma cells under hypoxic and acidic conditions in vitro. Br J Cancer 1997;76:421-8.
6. Ward JF. Mechanisms of DNA repair and their potential modification for radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:1027-32.
7. Nagle WA, Moss Jr. AJ, Roberts Jr. HG, Baker ML. Effects of 5-thio-D-glucose on cellular adenosine triphosphate levels and deoxyribonucleic acid rejoining in hypoxic and aerobic Chinese hamster cells. Radiology 1980;137:203-11.
8. Spiro IJ, Kennedy KA, Stickler R, Ling CC. Cellular and molecular repair of X-ray-induced damage: Dependence on oxygen tension and nutritional status. Radiat Res 1985;101:144-55.
9. Hall EJ, Bedford JS, Oliver R. Extreme hypoxia; its effect on the survival of mammalian cells irradiated at high and low dose-rates. Br J Radiol 1966;39:302-7.
10. Berry RJ, Hall EJ, Cavanagh J. Radiosensitivity and the oxygen effect for mammalian cells cultured in vitro in stationary phase. Br J Radiol 1970;43:81-90.
11. Franko AJ, Sutherland RM. Radiation survival of cells from spheroids grown in different oxygen concentrations. Radiat Res 1979;79:454-67.
12. Shrieve DC, Harris JW. The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-radiation and hypoxic cell radiosensitizers. Int J Radiat Biol 1985;48:127-38.
13. Ling CC, Robinson E, Shrieve DC. Repair of radiation induced damage-dependence on oxygen and energy status. Int J Radiat Oncol Biol Phys 1988;15:1179-86.
14. Pettersen EO, Wang H. Radiation-modifying effect of oxygen in synchronized cells pre-treated with acute or prolonged hypoxia. Int J Radiat Biol 1996;70:319-26.
15. Zölzer F, Streffer C. Increased radiosensitivity with chronic hypoxia in four human tumor cell lines. Int J Radiat Oncol Biol Phys 2002;54:910-20.
16. Denekamp J, Daşu A. Inducible repair and the two forms of tumour hypoxia - time for a paradigm shift. Acta Oncol 1999;38:903-18.
17. Daşu A, Denekamp J. The impact of tissue microenvironment on treatment simulation. Adv Exp Med Biol 2003;510:63-7.
18. Daşu A, Toma-Daşu I, Karlsson M. Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia. Phys Med Biol 2003;48:2829-42.
19. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-49.
20. Tannock IF. The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer 1968;22:258-73.
21. Brown JM. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 1979;52:650-6.
22. Alper T, Howard-Flanders P. Role of oxygen in modifying the radiosensitivity of E. Coli B. Nature 1956;178:978-9.
23. Kellerer AM, Rossi HH. The theory of dual radiation action. Curr Top Radiat Res Q 1972;8:85-158.
24. Chadwick KH, Leenhouts HP. A molecular theory of cell survival. Phys Med Biol 1973;18:78-87.
25. Douglas BG, Fowler JF. Fractionation schedules and a quadratic dose-effect relationship. Br J Radiol 1975;48:502-4.
26. Barendsen GW. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982;8:1981-97.
27. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
28. Joiner MC, Denekamp J, Maughan RL. The use of 'top-up' experiments to investigate the effect of very small doses per fraction in mouse skin. Int J Radiat Biol 1986;49:565-80.
29. Joiner MC, Johns H. Renal damage in the mouse: The response to very small doses per fraction. Radiat Res 1988;114:385-98.
30. Hamilton CS, Denham JW, O'Brien M, Ostwald P, Kron T, Wright S et al. Underprediction of human skin erythema at low doses per fraction by the linear quadratic model. Radiother Oncol 1996;40:23-30.
31. Turesson I, Johansson K-A, Nyman J, Flogegard M, Wahlgren T. A clinical study on the effect of low dose per fraction. Radiother Oncol 1998;48(Suppl 1):S4.
32. Beck-Bornholdt H-P, Maurer T, Becker S, Omniczynski M, Vogler H, Würschmidt F. Radiotherapy of the rhabdomyosarcoma R1H of the rat: Hyperfractionation-126 fractions applied within 6 weeks. Int J Radiat Oncol Biol Phys 1989;16:701-5.
33. Harney J, Short SC, Shah N, Joiner M, Saunders MI. Low dose hyper-radiosensitivity in metastatic tumors. Int J Radiat Oncol Biol Phys 2004;59:1190-5.
34. Marples B, Joiner MC. The response of Chinese hamster V79 cells to low radiation doses: Evidence of enhanced sensitivity of the whole cell population. Radiat Res 1993;133:41-51.
35. Lambin P, Marples B, Fertil B, Malaise EP, Joiner MC. Hypersensitivity of a human tumour cell line to very low radiation doses. Int J Radiat Biol 1993;63:639-50.
36. Wouters BG, Skarsgard LD. The response of a human tumor cell line to low radiation doses: Evidence of enhanced sensitivity. Radiat Res 1994;138:S76-S80.
37. Singh B, Arrand JE, Joiner MC. Hypersensitive response of normal human lung epithelial cells at low radiation doses. Int J Radiat Biol 1994;65:457-64.
38. Wouters BG, Sy AM, Skarsgard LD. Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different radiosensitivity. Radiat Res 1996;146:399-413.
39. Marples B, Adomat H, Koch CJ, Skov KA. Response of V79 cells to low doses of X-rays and negative π-mesons: clonogenic survival and DNA strand breaks. Int J Radiat Biol 1996;70:429-36.
40. Wouters BG, Skarsgard LD. Low-dose radiation sensitivity and induced radioresistance to cell killing in HT-29 cells is distinct from the "adaptive response" and cannot be explained by a subpopulation of sensitive cells. Radiat Res 1997;148:435-42.
41. Short S, Mayes C, Woodcock M, Johns H, Joiner MC. Low dose hypersensitivity in the T98G human glioblastoma cell line. Int J Radiat Biol 1999;75:847-55.
42. Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Low-dose hypersensitivity: Current status and possible mechanisms. Int J Radiat Oncol Biol Phys 2001;49:379-89.
43. Joiner MC, Lambin P, Malaise EP, Robson T, Arrand JE, Skov KA et al. Hypersensitivity to very-low single radiation doses: Its relationship to the adaptive response and induced radioresistance. Mutat Res 1996;358:171-83.
44. Robson T, Joiner MC, Wilson GD, McCullough W, Price ME, Logan I et al. A novel human stress response-related gene with a potential role in induced radioresistance. Radiat Res 1999;152:451-61.
45. Marples B, Wouters BG, Collis SJ, Chalmers AJ, Joiner MC. Low-dose hyper-radiosensitivity: A consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells. Radiat Res 2004;161:247-55.
46. Lind BK, Persson LM, Edgren MR, Hedlof I, Brahme A. Repairable- conditionally repairable damage model based on dual Poisson processes. Radiat Res 2003;160:366-75.
47. Daşu A. Modelling the impact of two forms of hypoxia on novel radiotherapy approaches. 2000. PhD thesis, Umeå University.
48. Thames HD, Bentzen SM, Turesson I, Overgaard M, Van den Bogaert W. Time-dose factors in radiotherapy: A review of the human data. Radiother Oncol 1990;19:219-35.
49. Konerding MA, Malkusch W, Klapthor B, van Ackern C, Fait E, Hill SA et al. Evidence for characteristic vascular patterns in solid tumours: Quantitative studies using corrosion casts. Br J Cancer 1999;80:724-32.
50. Jain RK. Determinants of tumor blood flow: A review. Cancer Res 1988;48:2641-58.
51. Vordermark D, Menke DR, Brown JM. Similar radiation sensitivities of acutely and chronically hypoxic cells in HT 1080 fibrosarcoma xenografts. Radiat Res 2003;159:94-101.
52. Fertil B, Malaise EP. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 1985;11:1699-707.
53. Ljungkvist AS, Bussink J, Kaanders JH, Wiedenmann NE, Vlasman R, van der Kogel AJ. Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model. Radiat Res 2006;165:326-36.
54. Foster CJ, Malone J, Orr JS, Macfarlane DE. The recovery of the survival curve shoulder after protracted hypoxia. Br J Radiol 1971;44:540-5.
55. Siemann DW, Hill RP, Bush RS. The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2: 95% O2) on the in vivo radiation response of a murine sarcoma. Int J Radiat Oncol Biol Phys 1977;2:903-11.
56. Kaanders JH, Pop LA, Marres HA, Liefers J, van den Hoogen FJ, van Daal WA et al. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer. Radiother Oncol 1998;48:115-22.
57. Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol 1998;46:135-46.
58. Stubbs M. Application of magnetic resonance techniques for imaging tumour physiology. Acta Oncol 1999;38:845-53.
59. Littbrand B. Survival characteristics of mammalian cell lines after single or multiple exposures to roentgen radiation under oxic or anoxic conditions. Acta Radiol Ther Phys Biol 1970;9:257-81.
60. Littbrand B, Edsmyr F, Révész L. A low dose-fractionation scheme for the radiotherapy of carcinoma of the bladder. Experimental background and preliminary results. Bull Cancer 1975;62:241-8.
61. Taylor YC, Brown JM. Radiosensitization in multifraction schedules. I. Evidence for an extremely low oxygen enhancement ratio. Radiat Res 1987;112:124-33.
62. Palcic B, Brosing JW, Skarsgard LD. Survival measurements at low doses: Oxygen enhancement ratio. Br J Cancer 1982;46:980-4.
63. Watts ME, Hodgkiss RJ, Jones NR, Fowler JF. Radiosensitization of Chinese hamster cells by oxygen and misonidazole at low X-ray doses. Int J Radiat Biol 1986;50:1009-21.
64. Skarsgard LD, Harrison I. Dose dependence of the oxygen enhancement ratio (OER) in radiation inactivation of Chinese hamster V79-171 cells. Radiat Res 1991;127:243-7.
65. Freyer JP, Jarrett K, Carpenter S, Raju MR. Oxygen enhancement ratio as a function of dose and cell cycle phase for radiation-resistant and sensitive CHO cells. Radiat Res 1991;127:297-307.
66. Daşu A, Denekamp J. New insights into factors influencing the clinically relevant oxygen enhancement ratio. Radiother Oncol 1998;46:269-77.
67. Daşu A, Denekamp J. Superfractionation as a potential hypoxic cell radiosensitizer: Prediction of an optimum dose per fraction. Int J Radiat Oncol Biol Phys 1999;43:1083-94.
68. Yaromina A, Zips D, Thames HD, Eicheler W, Krause M, Rosner A, et al. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: The need for a multivariate approach in biomarker studies. Radiother Oncol 2006;81:122-9.